Silicon Therapeutics acquisition integrating VantAI machine learning

Roivant said it had entered a definitive agreement to acquire Silicon Therapeutics. The release says physics-based approaches at Silicon Therapeutics are to be integrated with machine-learning approaches at VantAI, including the use of computational-physics simulations as training data for VantAI's degrader-specific deep learning models. The agreement was still subject to customary closing conditions.